Published in BMC Infect Dis on July 20, 2010
Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany. BMC Infect Dis (2013) 1.21
Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting. J Clin Microbiol (2011) 1.05
A cross sectional study of HPV type prevalence according to age and cytology. BMC Infect Dis (2013) 0.96
Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial. BMC Infect Dis (2013) 0.90
Distribution of high and low risk HPV types by cytological status: a population based study from Italy. Infect Agent Cancer (2011) 0.89
A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years. BMC Infect Dis (2013) 0.85
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? BMC Infect Dis (2013) 0.82
Oncogenic human papillomavirus genital infection in southern Iranian women: population-based study versus clinic-based data. Virol J (2012) 0.81
Specific genotypes of human papillomavirus in 125 high-grade squamous lesions and invasive cervical cancer cases from Congolese women. BMC Public Health (2014) 0.78
The impact of HPV female immunization in Italy: model based predictions. PLoS One (2014) 0.76
Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria. Infect Agent Cancer (2015) 0.76
HPV prevalence and risk of pre-cancer and cancer in regular immigrants in Italy: results from HPV DNA test-based screening pilot programs. Infect Agent Cancer (2015) 0.75
HPV Infection in a Cohort of HIV-Positive Men and Women: Prevalence of Oncogenic Genotypes and Predictors of Mucosal Damage at Genital and Oral Sites. J Sex Transm Dis (2013) 0.75
Six years genotype distribution of Human Papillomavirus in Calabria Region, Southern Italy: a retrospective study. Infect Agent Cancer (2017) 0.75
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Carcinogenicity of human papillomaviruses. Lancet Oncol (2005) 5.84
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol (2002) 5.63
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer (2006) 3.38
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol (2006) 2.59
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst (2008) 2.36
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev (2002) 2.24
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst (2006) 2.16
Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting. Am J Clin Pathol (2005) 1.80
Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer (2005) 1.40
Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol (2009) 1.12
AKEntAnnos. The Sardinia Study of Extreme Longevity. Aging (Milano) (1999) 1.12
Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J Clin Virol (2007) 1.06
Human Papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis (2009) 1.06
Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev (2008) 1.03
Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. J Med Virol (2006) 1.02
Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J Gen Virol (2008) 0.96
Estimation of Pap-test coverage in an area with an organised screening program: challenges for survey methods. BMC Health Serv Res (2006) 0.94
Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect Agent Cancer (2007) 0.92
Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy. Eur J Cancer (1997) 0.92
Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy). Vaccine (2009) 0.89
Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism. Virus Res (1997) 0.88
Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity. Epidemiol Prev (2009) 0.85
Prevalence of cervical human papillomavirus infection and types among women immigrated to Sicily, Italy. Acta Obstet Gynecol Scand (2009) 0.84
Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. J Clin Virol (2008) 0.83
Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population. BMC Infect Dis (2005) 0.79
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol (2013) 2.32
Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst (2013) 1.38
Uterine cervical carcinoma: role of matrix metalloproteinases (review). Int J Oncol (2009) 1.24
Road traffic injuries in Lazio, Italy: a descriptive analysis from an emergency department-based surveillance system. Ann Emerg Med (2005) 1.24
Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys (2010) 1.14
Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics (2009) 1.08
Mortality in elderly injured patients: the role of comorbidities. Int J Inj Contr Saf Promot (2008) 1.01
Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomarkers Prev (2010) 1.00
Paraneoplastic cerebellar degeneration associated with ovarian cancer. Oncol Lett (2012) 0.96
'Genetic profiling' and ovarian cancer therapy (review). Mol Med Rep (2011) 0.95
Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment. Cancer (2005) 0.95
Dying of cancer in Italy: impact on family and caregiver. The Italian Survey of Dying of Cancer. J Epidemiol Community Health (2007) 0.93
Prognostic significance of p53 and Ki-67 antigen expression in surgically treated non-small cell lung cancer: immunocytochemical detection with imprint cytology. Am J Clin Pathol (2006) 0.90
Distribution of high and low risk HPV types by cytological status: a population based study from Italy. Infect Agent Cancer (2011) 0.89
Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study. J Clin Microbiol (2013) 0.89
Correlation of the risk of breast cancer and disruption of the circadian rhythm (Review). Oncol Rep (2012) 0.89
Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis. J Med Screen (2010) 0.87
Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy. Health Policy (2010) 0.87
Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review). Mol Med Rep (2010) 0.86
[Record-linkage procedures in epidemiology: an Italian multicentre study]. Epidemiol Prev (2008) 0.86
Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy. Front Oncol (2014) 0.85
Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity. Epidemiol Prev (2009) 0.85
Evaluation of the health effects of the new driving penalty point system in the Lazio Region, Italy, 2001-4. Inj Prev (2007) 0.84
Unintentional home injuries reported by an emergency-based surveillance system: incidence, hospitalisation rate and mortality. Accid Anal Prev (2006) 0.84
Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study. Int J Cancer (2013) 0.83
Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease. J Clin Microbiol (2006) 0.83
Conventional pap smear and liquid-based cervical cytology smear: comparison from the same patient. Tumori (2002) 0.82
Comparison of the conventional cervical smear and liquid-based cytology: results of a controlled, prospective study in the Abruzzo Region of Italy. Acta Cytol (2008) 0.81
Activity level and process indicators of organised programmes for cervical cancer screening in Italy. Epidemiol Prev (2006) 0.81
[Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy]. Epidemiol Prev (2012) 0.81
Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2009 activity. Epidemiol Prev (2011) 0.80
Extension of organised cervical cancer screening programmes in Italy and their process indicators. Epidemiol Prev (2008) 0.79
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies. Infect Agent Cancer (2012) 0.79
[Feasibility of behavioural interventions for tobacco smoking cessation in routine general practice]. Ig Sanita Pubbl (2007) 0.78
Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis. Lung Cancer (2009) 0.78
Home injuries mortality: sensitivity and specificity analysis of different data sources and operative definitions. Accid Anal Prev (2007) 0.78
Early and mid-term clinical outcome of emergency PCI in patients with STEMI due to unprotected left main coronary artery disease. J Interv Cardiol (2012) 0.78
Efficacy of disease management profiles. The mammographic screening program of Lazio. Tumori (2008) 0.78
Triage and Injury Severity Scores as predictors of mortality and hospital admission for injuries: a validation study. Accid Anal Prev (2010) 0.77
Agreement between emergency room and discharge diagnoses in a population of injured inpatients: determinants and mortality. J Trauma (2007) 0.77
Impact of p16(INK4a) immunohistochemistry staining on interobserver agreement on the diagnosis of cervical intraepithelial neoplasia. Am J Clin Pathol (2014) 0.77
[Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity]. Epidemiol Prev (2013) 0.76
A case-control study on risk factors of domestic accidents in an elderly population. Int J Inj Contr Saf Promot (2011) 0.76
Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2008 activity. Epidemiol Prev (2011) 0.76
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy. Curr Pharm Des (2016) 0.75
Extension of organised cervical cancer screening programmes in Italy and their process indicators. Epidemiol Prev (2007) 0.75
The effect of screening programmes on the treatment of benign breast neoplasms: observations from current practice in Italy. J Med Screen (2006) 0.75
The diffusion of screening programmes in Italy, years 2011-2012. Epidemiol Prev (2015) 0.75
How socioeconomic status influences road traffic injuries and home injuries in Rome. Int J Inj Contr Saf Promot (2012) 0.75
hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi). Epidemiol Prev (2015) 0.75